Drug shortage: Azacitidine Injection (VIDAZA, AZACITIDINE)
FDA lists 9 presentations as Current. Availability: Unavailable (4), Limited Availability (1), Available (4). Reason: Other; Demand increase for the drug. Companies: Bristol Myers Squibb Co., Armas Pharmaceuticals Inc, Eugia US LLC, Teva Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC….
- Published by source
- 2020-12-18
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Bristol Myers Squibb Co.
- Products
- Azacitidine Injection VIDAZA AZACITIDINE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
- On backorder. Recovery: TBD. Check wholesalers for inventory
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-12-18
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #866 | new | 2026-10-22 | 155cffabd466…cfbb84 | 1e5265ca9eed…dc426c |
| #1177 | update | 2026-10-23 | df9f8125cdef…0acb7e | 70cb39acfa57…9f11b0 |
| #1375 | update | 2026-10-23 | 6d7710171cdc…5a8104 | 1de366017a10…4bdcd2 |
Chain head: #1479 ad3417dbc128…777bd4